Page 9 - Science 37 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

An expert from the decentralized study solutions company shares perspectives on the importance of inclusivity and solutions that could improve representation.

Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers Using Science 37's decentralized clinical trial model, the partnership offers Xperiome's research-ready, rare disease patients more study opportunities with less burden. News provided by Share this article Share this article LOS ANGELES, March 11, 2021 /PRNewswire/ -- Science 37, the industry leader in decentralized clinical trials, announced today a partnership with Xperiome, a global rare disease healthtech company. The partnership further strengthens Science 37's ca...

Science 37® and Medgate Partner to Further Globalize Decentralized Clinical Trials With a presence in Europe, Asia-Pacific, and the Middle East, Medgate extends the Science 37 Decentralized Clinical Trial Operating System--enabling more provider and patient research participation. News provided by Share this article Share this article LOS ANGELES, March 2, 2021 /PRNewswire/ -- Science 37, the industry leader in decentralized clinical trials, announced today a strategic partnership with Medgate, a leading international digital health and telemedicine company and operator of Europe's largest t...

/PRNewswire/ -- Science 37, the industry leader in decentralized clinical trials, today announced a premier partnership program, Science 37 Certified, designed...